Whalesbook
Fidelity Ne Pharma Mein Paisa Lagaya!
Fidelity Securities Fund ne apne Fidelity Blue Chip Growth Fund ke through Onesource Specialty Pharma mein entry li hai. Unhone ₹308.7 crore lagakar 1.76% stake kharida hai. Is deal mein Authum Investment & Infrastructure aur Nova Global Opportunities Fund ne apne shares beche, value thi ₹118.9 crore aur ₹161.85 crore respectively. Iske baad Onesource ka stock 0.7% badhkar ₹1,560.70 par pahunch gaya, aur volume bhi accha tha. India ka pharma sector, especially CDMOs, 2026 tak acha perform karne wala hai. Analysts kaafi positive hain, sab 'Buy' rating de rahe hain aur average target price ₹1,943.50 diya hai, matlab 26% se zyada upside possible hai. Haalanki, company ka P/E ratio 101.10 ke aas-paas hai jo kaafi high hai, lekin acha EBITDA margin aur expansion plans hain. Pichle saal stock ka performance modest raha tha, toh yeh institutional interest ek catalyst ban sakta hai, par execution risk aur valuation pe nazar rakhni padegi.
Jewelry Stock Mein Promoter Exit, Telecom Mein Speculative Surge!
Jewelry sector mein, Shringar House of Mangalsutra se Thakkar Vardhilal Shivrambhai ne poori tarah exit maar liya hai. Unhone 15.55 lakh shares ₹31.9 crore mein bech diye. Wiinance Financial Services aur Arthkumbh Ventures LLP ne ye shares kharide hain. Iske baad Shringar ka stock thoda sa 1.76% badhkar ₹205.36 par pahunch gaya. Ek analyst isko 'Strong Buy' bol raha hai ₹315 ke target ke saath, lekin MarketsMojo technicals ki wajah se 'Hold' rating de raha hai, fundamentals ache hone ke bawajood. Indian jewelry market gold prices high hone ke baad bhi resilient dikh rahi hai.
Meanwhile, Shyam Telecom mein toh dhamaka ho gaya! Stock seedha 20% upper circuit laga kar ₹12.84 par close hua. Ye move isliye aaya kyunki Meghna Agarwal ne 0.97% stake sirf ₹14.01 lakh mein kharida tha. Ye rally company ke kharab financials ke bilkul opposite hai. Shyam Telecom ka P/E ratio negative -2.08 hai, book value negative hai, aur earnings bhi gir rahi hain. Market cap bhi chhota sa hai, lagbhag ₹11-14 crore. Ye rally purely speculative interest ke karan hai, fundamental strength ka koi sign nahi, so it's a very high-risk bet.
Kaun Kaisa Perform Karega?
Onesource Specialty Pharma ke liye analysts ka median target ₹1,943.50 hai, jo growth dikhata hai. Par investors ko execution challenges aur regulatory hurdles pe dhyan dena chahiye. Shringar House of Mangalsutra ka outlook balanced hai, 'Hold' rating aur ₹315 ke target ke saath stability dikh rahi hai, promoter ke exit ke baad growth thoda uncertain hai. Shyam Telecom ka future bilkul uncertain hai companies ke kharab financial condition ke karan, iska koi bhi upward movement fundamental improvement ke bina sustainable nahi hoga aur purely speculative hi rahega.